Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Darryle D Schoepp

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Nature Reviews. Drug Discovery|October 1, 2011
Where will new neuroscience therapies come from?Darryle D Schoepp
Pharmacology, Biochemistry, and Behavior|July 18, 2024
mGlu2/3 receptor agonist (LY354740) in anxietyDarryle D Schoepp
Progress in Brain Research|March 31, 2021
Cortical influences of serotonin and glutamate on layer V pyramidal neuronsGerard J Marek, Darryle D Schoepp
The Journal of Pharmacology and Experimental Therapeutics|November 20, 2002
The group II metabotropic glutamate receptor agonist (-)-2-oxa-4-aminobicyclo[3.1.0.]hexane-4,6-dicarboxylate (LY379268) and clozapine reverse phencyclidine-induced behaviors in monoamine-depleted ratsChad J Swanson, Darryle D Schoepp
Annals of the New York Academy of Sciences|December 20, 2003
A role for noradrenergic transmission in the actions of phencyclidine and the antipsychotic and antistress effects of mGlu2/3 receptor agonistsChad J Swanson, Darryle D Schoepp
Current Drug Targets. CNS and Neurological Disorders|May 29, 2003
Preclinical pharmacology of mGlu2/3 receptor agonists: novel agents for schizophrenia?Darryle D Schoepp DD, Gerard J Marek
Journal of Neurochemistry|December 17, 2003
The mGlu2/3 receptor agonist, LY354740, blocks immobilization-induced increases in noradrenaline and dopamine release in the rat medial prefrontal cortexChad J Swanson, Kenneth W Perry, Darryle D Schoepp
Pharmacology, Biochemistry, and Behavior|July 16, 2002
The anxiolytic action of mGlu2/3 receptor agonist, LY354740, in the fear-potentiated startle model in rats is mechanistically distinct from diazepamJoseph P Tizzano, Kelly I Griffey, Darryle D Schoepp
Neuroscience Letters|June 9, 2006
5-Hydroxytryptamine2A (5-HT2A) receptor regulation in rat prefrontal cortex: interaction of a phenethylamine hallucinogen and the metabotropic glutamate2/3 receptor agonist LY354740Gerard J Marek, Rebecca A Wright, Darryle D Schoepp
Neuropharmacology|August 9, 2003
Systemic administration of the potent mGlu8 receptor agonist (S)-3,4-DCPG induces c-Fos in stress-related brain regions in wild-type, but not mGlu8 receptor knockout miceAnni-Maija Linden, Marcelle Bergeron, Melvyn Baez, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Nature Reviews. Drug Discovery|October 1, 2011
Where will new neuroscience therapies come from?Darryle D Schoepp
Pharmacology, Biochemistry, and Behavior|July 18, 2024
mGlu2/3 receptor agonist (LY354740) in anxietyDarryle D Schoepp
Progress in Brain Research|March 31, 2021
Cortical influences of serotonin and glutamate on layer V pyramidal neuronsGerard J Marek, Darryle D Schoepp
The Journal of Pharmacology and Experimental Therapeutics|November 20, 2002
The group II metabotropic glutamate receptor agonist (-)-2-oxa-4-aminobicyclo[3.1.0.]hexane-4,6-dicarboxylate (LY379268) and clozapine reverse phencyclidine-induced behaviors in monoamine-depleted ratsChad J Swanson, Darryle D Schoepp
Annals of the New York Academy of Sciences|December 20, 2003
A role for noradrenergic transmission in the actions of phencyclidine and the antipsychotic and antistress effects of mGlu2/3 receptor agonistsChad J Swanson, Darryle D Schoepp
Current Drug Targets. CNS and Neurological Disorders|May 29, 2003
Preclinical pharmacology of mGlu2/3 receptor agonists: novel agents for schizophrenia?Darryle D Schoepp DD, Gerard J Marek
Journal of Neurochemistry|December 17, 2003
The mGlu2/3 receptor agonist, LY354740, blocks immobilization-induced increases in noradrenaline and dopamine release in the rat medial prefrontal cortexChad J Swanson, Kenneth W Perry, Darryle D Schoepp
Pharmacology, Biochemistry, and Behavior|July 16, 2002
The anxiolytic action of mGlu2/3 receptor agonist, LY354740, in the fear-potentiated startle model in rats is mechanistically distinct from diazepamJoseph P Tizzano, Kelly I Griffey, Darryle D Schoepp
Neuroscience Letters|June 9, 2006
5-Hydroxytryptamine2A (5-HT2A) receptor regulation in rat prefrontal cortex: interaction of a phenethylamine hallucinogen and the metabotropic glutamate2/3 receptor agonist LY354740Gerard J Marek, Rebecca A Wright, Darryle D Schoepp
Neuropharmacology|August 9, 2003
Systemic administration of the potent mGlu8 receptor agonist (S)-3,4-DCPG induces c-Fos in stress-related brain regions in wild-type, but not mGlu8 receptor knockout miceAnni-Maija Linden, Marcelle Bergeron, Melvyn Baez, et al.
Pageof 4